全文获取类型
收费全文 | 5974篇 |
免费 | 296篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 357篇 |
妇产科学 | 67篇 |
基础医学 | 659篇 |
口腔科学 | 174篇 |
临床医学 | 460篇 |
内科学 | 1117篇 |
皮肤病学 | 249篇 |
神经病学 | 335篇 |
特种医学 | 140篇 |
外科学 | 946篇 |
综合类 | 108篇 |
一般理论 | 3篇 |
预防医学 | 249篇 |
眼科学 | 285篇 |
药学 | 646篇 |
1篇 | |
中国医学 | 34篇 |
肿瘤学 | 425篇 |
出版年
2023年 | 35篇 |
2022年 | 117篇 |
2021年 | 260篇 |
2020年 | 133篇 |
2019年 | 149篇 |
2018年 | 174篇 |
2017年 | 113篇 |
2016年 | 164篇 |
2015年 | 194篇 |
2014年 | 243篇 |
2013年 | 330篇 |
2012年 | 490篇 |
2011年 | 494篇 |
2010年 | 253篇 |
2009年 | 204篇 |
2008年 | 370篇 |
2007年 | 369篇 |
2006年 | 333篇 |
2005年 | 329篇 |
2004年 | 333篇 |
2003年 | 274篇 |
2002年 | 223篇 |
2001年 | 67篇 |
2000年 | 50篇 |
1999年 | 59篇 |
1998年 | 72篇 |
1997年 | 33篇 |
1996年 | 28篇 |
1995年 | 33篇 |
1994年 | 26篇 |
1993年 | 26篇 |
1992年 | 35篇 |
1991年 | 27篇 |
1990年 | 29篇 |
1989年 | 24篇 |
1988年 | 10篇 |
1987年 | 16篇 |
1986年 | 12篇 |
1985年 | 11篇 |
1984年 | 15篇 |
1983年 | 7篇 |
1982年 | 17篇 |
1981年 | 17篇 |
1980年 | 18篇 |
1979年 | 13篇 |
1978年 | 18篇 |
1977年 | 11篇 |
1976年 | 10篇 |
1975年 | 5篇 |
1974年 | 5篇 |
排序方式: 共有6299条查询结果,搜索用时 265 毫秒
991.
992.
993.
Jeff Unger MD Dale C. Allison MD Margit Kaltoft MD Kavitha Lakkole MBA Jayant K. Panda MD Chethana Ramesh MSc Mehmet Sargin MD Elena Smolyarchuk MD Melissa Twine BS Benjamin Wolthers MD Gizem Yarimbas MSc Marouan Zoghbi MD the LIRA-PRIME investigators 《Diabetes, obesity & metabolism》2022,24(2):204-211
994.
995.
996.
Jedas Veronica Daag Michelle Ylade Cameron Adams Ramesh Jadi Maria Vinna Crisostomo Riacarl Alpay Emma Teresa Carmela Aportadera In-Kyu Yoon Laura White Jacqueline Deen Aravinda M. de Silva Anna Lena Lopez 《Clinical microbiology and infection》2021,27(6):904-908
ObjectiveVaccination with the first licensed dengue vaccine is recommended only for those who have had previous infection with dengue virus (DENV). A point-of-care test with the desired sensitivity of 95% and specificity of 98% could facilitate pre-vaccination screening. We evaluated a newly developed, automated dengue immunoglobulin fluorescence immunoassay for determining dengue serostatus.MethodsWe used serum samples collected just prior to a mass dengue vaccination in Cebu, Philippines. Healthy children residing in Bogo and Balamban who would be 9–14 years old at the time of the mass dengue vaccination were eligible to participate. We evaluated the ichroma? II dengue fluorescence immunoassay (Boditech Med Incorporated, Gang-won-do, Republic of Korea) using a neutralization test (NT) as the reference assay.ResultsWe enrolled 2996 children (mean age 10.39 years, 51.7% female) in the cohort and included a subsample of 1000 (mean age 10.56 years, 54.4% female) in this study. Of the 1000 children, 86/1000 (8.6%) tested seronegative and 914/1000 (91.4%) seropositive for DENV antibodies by neutralization testing. Compared with the NT, the dengue IgG fluorescence immunoassay had an overall specificity of 90.7% (95%CI: 82.5–95.9%) and a sensitivity of 91.8% (95%CI: 89.8–93.5%) for determining dengue seropositivity. The sensitivity declined to 51.2% (42.3–61.0%) for the detection of the subset with a monotypic dengue profile.ConclusionThe insufficient specificity and sensitivity (particularly in the detection of a previous monotypic dengue infection) would render the test, in its current state, inadequate for pre-vaccination screening. Considering its user-friendly interphase and possibility of point-of-care use, the test could be further developed and validated to improve its performance characteristics. 相似文献
997.
Caitlin A. Schonewolf Marina Heskel Abigail Doucette Sunil Singhal Melissa A. Frick Eric P. Xanthopoulos Michael N. Corradetti Joseph S. Friedberg Taine T. Pechet John P. Christodouleas William Levin Abigail Berman Keith A. Cengel Vivek Verma Stephen M. Hahn John C. Kucharczuk Ramesh Rengan Charles B. Simone 《Clinical lung cancer》2019,20(1):e63-e71
Background
Stereotactic body radiation therapy (SBRT) is standard for medically inoperable stage I non–small-cell lung cancer (NSCLC) and is emerging as a surgical alternative in operable patients. However, limited long-term outcomes data exist, particularly according to operability. We hypothesized long-term local control (LC) and cancer-specific survival (CSS) would not differ by fractionation schedule, tumor size or location, or operability status, but overall survival (OS) would be higher for operable patients.Patients and Methods
All consecutive patients with stage I (cT1-2aN0M0) NSCLC treated with SBRT from June 2009 to July 2013 were assessed. Thoracic surgeon evaluation determined operability. Local failure was defined as growth following initial tumor shrinkage or progression on consecutive scans. LC, CSS, and OS were calculated using Cox proportional hazards regression.Results
A total of 186 patients (204 lesions) were analyzed. Most patients were inoperable (82%) with Eastern Cooperative Oncology Group performance status of 1 (59%) or 2 (26%). All lesions received biological effective doses ≥ 100 Gy most commonly (94%) in 3 to 5 fractions. The median follow-up was 4.0 years. LC at 2 and 5 years were 95.6% (95% confidence interval, 92%-99%) and 93.7% (95% confidence interval, 90%-98%), respectively. Compared with operable patients, inoperable patients did not have significant differences in 5-year LC (93.1% vs. 96.7%; P = .49), nodal failure (31.4% vs. 11.0%; P = .12), distant failure (12.2% vs. 10.4%; P = .98), or CSS (80.6% vs. 91.0%; P = .45) but trended towards worse OS (34.2% vs. 45.3%; P = .068). Tumor size, location, and fractionation did not significantly influence outcomes.Conclusions
SBRT has excellent, durable LC and CSS rates for early-stage NSCLC, although inoperable patients had somewhat lower OS than operable patients, likely owing to greater comorbidities. 相似文献998.
The novel ternary carbides and nitrides, known as MAX phase materials with remarkable combined metallic and ceramic properties, offer various engineering and technological applications. Using ab initio calculations based on generalized gradient approximation (GGA), local density approximation (LDA), and the quasiharmonic Debye model; the electronic, structural, elastic, mechanical, and thermodynamic properties of the M2GaC (M = Zr, Hf) MAX phase were investigated. The optimized lattice parameters give the first reference to the upcoming theocratical and experimental studies, while the calculated elastic constants are in excellent agreement with the available data. Moreover, obtained elastic constants revealed that both the Zr2GaC and Hf2GaC MAX phases are brittle. The band structure and density of states analysis showed that these MAX phases are electrical conductors, having strong directional bonding between M-C (M = Zr, Hf) atoms due to M-d and C-p hybridization. Formation and cohesive energies, and phonon calculations showed that Zr2GaC and Hf2GaC MAX phases’ compounds are thermodynamically and dynamically stable and can be synthesized experimentally. Finally, the effect of temperature and pressure on volume, heat capacity, Debye temperature, Grüneisen parameter, and thermal expansion coefficient of M2GaC (M = Zr, Hf) are evaluated using the quasiharmonic Debye model from the nonequilibrium Gibbs function in the temperature and pressure range 0–1600 K and 0–50 GPa respectively. 相似文献
999.
1000.
South Asians (SA) are at higher cardiovascular risk than other ethnic groups, and SA kidney transplant recipients (SA KTR) are no exception. SA KTR experience increased major adverse cardiovascular events both early and late post-transplantation. Cardiovascular risk management should therefore begin well before transplantation. SA candidates may require aggressive screening for pre-transplant cardiovascular disease (CVD) due to their ethnicity and comorbidities. Recording SA ethnicity during the pre-transplant evaluation may enable pro grams to better assess cardiovascular risk, thus allowing for earlier targeted peri- and post-transplant intervention to improve cardiovascular outcomes. Diabetes remains the most prominent post-transplant cardiovascular risk factor in SA KTR. Diabetes also clusters with other metabolic syndrome components including lower high-density lipoprotein cholesterol, higher triglycerides, hypertension, and central obesity in this population. Dyslipidemia, metabolic syndrome, and obesity are all significant CVD risk factors in SA KTR, and contribute to increased insulin resistance. Novel biomarkers such as adiponectin, apolipoprotein B, and lipoprotein (a) may be especially important to study in SA KTR. Focused interventions to improve health behaviors involving diet and exercise may especially benefit SA KTR. However, there are few interventional clinical trials specific to the SA population, and none are specific to SA KTR. In all cases, understanding the nuances of managing SA KTR as a distinct post-transplant group, while still screening for and managing each CVD risk factor individually in all patients may help improve the long-term success of all kidney transplant programs catering to multi-ethnic populations. 相似文献